Kari Kendra

机构：The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University · ORCID：0000-0001-5936-6689

发表论文 269 篇 · 总被引 8769 次 · h-index 42

代表论文

• Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology (2025 · Journal of the National Comprehensive Cancer Network · 被引 22)
• DREAMseq: A phase III trial of treatment sequences in BRAFV600-mutant (m) metastatic melanoma (MM)—Final clinical results. (2025 · Journal of Clinical Oncology · 被引 10)
• BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy (2025 · Journal of Clinical Investigation · 被引 8)
• Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial (2025 · Nature Medicine · 被引 7)
• Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors (2024 · JCI Insight · 被引 7)
• 1601O 3-year survival with neoadjuvant-adjuvant pembrolizumab from SWOG S1801 (2025 · Annals of Oncology · 被引 5)